Neoplasm by Special Category — Trials

Neoplasm by Special Category — Trials · CancerIndex

Clinical trials

Registered studies

95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 351–400 of 13,627 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00183820	Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma	completed	Phase 2	30	University of Southern CaliforniaOTHER	1	Jul 1, 2026	clinicaltrials
NCT01862315	Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)	completed	Phase 2	56	Memorial Sloan Kettering Cancer CenterOTHER	1